Quality of Life in Parkinson´s Disease Patients with Depression and Impulsive-compulsive Behaviors
Objective: To analyze quality of life (QoL) in Parkinson´s disease (PD) patients regarding to have depression, impulsive-compulsive behaviors (ICBs), or both. Background: Depression and ICBs are…The clinical features of non-motor symptoms in Parkinson’s Disease with Rapid Eye Movement Sleep Behavior Disorder(RBD)
Objective: To review non-motor symptoms of PD with RBD, To explore the effects of RBD on PD. Background: Non-motor symptoms of PD with RBD were…Characterization of striatal dopaminergic neurotransmission in the rat pre-formed fibril models of Parkinson’s disease
Objective: To determine the longitudinal effects of synucleinopathy and synucleinopathy-triggered nigrostriatal degeneration on basal and evoked striatal dopamine (DA) release in the striatum at 4…Parkinson’s disease and chronic inflammatory demyelinating polyneuropathy with celiac disease: Improvement in neuropathy but not Parkinson’s symptoms after intravenous immunoglobulin and gluten free diet
Objective: To report a case of celiac disease in Parkinson's disease and CIPD, and examine the relationship. Background: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) is a…Identification and Documentation of Delirium in Parkinson’s Disease
Objective: To establish documentation, assessment and diagnosis practices in the medical notes of inpatients with Parkinson’s disease (PD) and delirium. Background: Delirium is a neuropsychiatric…Association between BDNF Val66Met polymorphism and mild behavioral impairment in patients with Parkinson’s patients
Objective: This study investigates if PD patients with Brain-derived-neurotrophic-factor (BNDF) Met allele are more likely to have Mild behavioral impairment (MBI). And whether Met allele…The Personalized Parkinson Project – data quality enhancing strategies
Objective: Demonstrate the impact of quality enhancing strategies in the Personalized Parkinson Project. Background: Increasingly, the scientific community uses data from longitudinal observational patient cohorts…AADC gene therapy administered via a posterior approach: 18-month results from the PD-1102 trial in advanced Parkinson’s disease
Objective: To report 18-month safety and clinical outcomes from a phase 1, open-label trial of VY-AADC01 (NBIb-1817) for Parkinson’s disease (PD) patients with motor fluctuations.…Comparison of Categorical- and Verbatim-Reported Postural Instability Symptoms Among Fox Insight Parkinson Research Participants
Objective: To analyze verbatim patient-reported problems compared with ordinal measures referable to Postural Instability (PI) symptoms in the Fox Insight (FI) observational study. Background: FI…Prospective assessment of the lessebo effect in placebo-controlled randomized trials using an expectancy questionnaire
Objective: To prospectively measure the lessebo effect using an expectancy questionnaire (EQ). Background: The presence of a placebo arm in a randomized controlled trial has…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 149
- Next Page »